Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults. uri icon

authors

  • Schmader, Kenneth E
  • Oostvogels, Lidia
  • Curran, Desmond
  • Levin, Myron J
  • Chen, Michael
  • Matthews, Sean
  • Riley, Megan E
  • Woo, Wayne
  • HervĂ©, Caroline
  • Grupping, Katrijn
  • Schuind, Anne E

publication date

  • February 25, 2021